ARFXF Stock Price, News & Analysis
Company Description
ARFXF (OTC: ARFXF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $44.0M.
ARFXF stock has declined 10.4% over the past year.
This page provides a comprehensive overview of ARFXF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ARFXF (ARFXF) stock. Over the past 12 months, the stock has lost 10.4%. At a market capitalization of $44.0M, ARFXF is classified as a micro-cap stock with approximately 431.7M shares outstanding.
Latest News
ARFXF has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 1 with negative movement. Key topics include earnings, conferences, stock split. View all ARFXF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ARFXF Company Profile & Sector Positioning
ARFXF (ARFXF) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing ARFXF often look at related companies in the same sector, including Telomir Pharms (TELO), Renovaro (RENB), Barinthus Biotherapeutics plc (BRNS), Medivir Ser (MVRBF), and Bioatla, Inc. (BCAB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ARFXF's relative position within its industry.